Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Omeros reports new data from pivotal trial of narsoplimab for HSCT-TMA

March 3, 2020

Phase I data for novel lentiviral vector therapy for children with Fanconi anemia

Feb. 28, 2020

Bluebird bio presents phase I/II data on LentiGlobin for sickle cell disease

Feb. 25, 2020

Phase IIb results presented for dalcinonacog alfa in hemophilia B patients

Feb. 12, 2020

AMT-060 gene therapy provides long-term factor IX activity in hemophilia B patients

Feb. 10, 2020

Thrombosis leads to early termination of phase II BAY-1093884 trial

Feb. 10, 2020

First-in-human data show safety and early hemostatic efficacy of BAY-2599023

Feb. 10, 2020

Verseon divulges new thrombin inhibitors

Feb. 4, 2020

Initial first-in-human data presented for OTL-102

Feb. 4, 2020

Bayer presents data from the phase II FOXTROT study of osocimab

Feb. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...